Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by Gilly123on Mar 26, 2021 1:38pm
209 Views
Post# 32887177

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Price action

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Price actionLOL you are so predictable... . The fundamentals are not as important but they still exist man. An example of this is increased political support in the space.

If we look technical chart we can find levels of previous support and resistance,  Theyre currently are two obvious levels around the $2 and $1 area.  Given that the volume is decreasing and we have no support until $2. I could see a slow trickle down without a positive catalyst.  Since we agree this is a spec play, the technical are really all that matter when predicting future price targets.  Right now the momentum is to the downside so I look to areas of previous support.  Also these large gaps are typically shorted after a big pump.

Does this provide you enough reasoning?

So again, now that we have cleared up that fundamentals exist, we can look to the technicals to find a future price. So why the heck would I buy at 3 plus dollars after a big spec pump?!!  Because we are in a short-mid term bearish trend and odds are I will make a lot more buying at $1-2.  Technical Technicals Technicals, This is a traders stock at the moment. 
<< Previous
Bullboard Posts
Next >>